Headache Main important for those profeccional students .ppt
yetalb
18 views
31 slides
May 17, 2024
Slide 1 of 31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
About This Presentation
this lecture note important for both medicine and psychiatric students
Size: 232.23 KB
Language: en
Added: May 17, 2024
Slides: 31 pages
Slide Content
Headache
.
Headache affects 95% of people
in their lifetime.
Headache affects 75% of people
in any one year.
One in 10 people have migraine.
One in 30 people have headache
more often than not, for 6
months or more.
Classification of Headache
1. Primary headaches –Idiopathic
with no identifiable underlying cause
Migraine
Tension-type headache
Cluster headache
Classification of Headache cont’d
2. Secondary headaches –
Symptomatic(organic)
Underlying condition such as
traumaor a mass lesion.
Intracranial diseases
Cranial trauma
Extra cranial causes –eye, ear
problems
Toxic or systemic illnesses –
febrile illnesses
History taking
1. Characteristics
of the pain
stabbing
Burning
Cold sensation
Crawling sensation
Itching sensation
Tightness
Heaviness
History taking cont’d
2. Localization and radiation
Generalized
Unilateral
Bi temporal
Occipital
Fronta
Periorbital
History taking cont’d
3. Pattern and duration
Intermittent-periodic
Continuous
In clusters
4. Time predilection
Nocturnal
On awakening
Afternoons
History taking cont’d
5. Aura symptoms
Presence or absence of aura
Characteristics of aura
Visual
Paresthesia
Olfactory
6. Associated symptoms
Nausea and vomiting
Photophobia
Noise intolerance
History taking cont’d
8. Current medication
prescription drugs -contribute/cause
headache (oral contraceptive,
dipyridamole, etc.)
Using recreational drugs
MIGRAINE
General features -migraine
Familial in 80% of cases
Usually begins in childhood or
adolescence
Precipitating factors
Stress
Diets –cheese, wine,
Sleep deprivation
Menses
Specific odor etc.
Classification of migraine(IHS)
1. Migraine without aura
2. Migraine with aura
Typical aura with migraine headache
Typical aura with non-migraine headache
Typical aura without headache
Migraine without aura (common migraine) -IHS
1. Five attacks lasting from 4 to 72 hours are
required.
2. Two of the following 3 pain characteristics:
unilateral location
moderate to severe intensity
aggravation by routine physical activity
3. Associated symptoms
Nausea or vomiting
Photophobia
Migraine with aura (classic migraine)
At least two attacks that are not
attributable to another disorder
Fewer attacks are required to make a
diagnosis of migraine with aura
May be less severe, of shorter duration, or
both
Aura -Visual Auras , Sensory auras
usually lasts 20–30 minutes
typically precedes the headache
occasionally it occurs only during the
headache.
Migraine Phases cont’d
Aura
•Sensory auras
Paresthesias (pins and needles)that
typically begin in the hand, move up the
arm
Move into the face and tongue over a
period of 10 to 15 minutes
Often associated with a visual aura
Migraine Phases cont’d
3. The headache itself
Throbbing headache
Unilateral mainly -frontal, temporal, peri
orbital
Onset is usually gradual
Usually lasts 4 to 72 hours in adults (2-48
hors in children)
Is aggravated by head movement or
physical activity.
Associated features
Nausea, vomiting
Photophobia
Migraine Phases cont’d
4. Postdrome or postictal phase
May feel tired, washed out, irritable and
listless
May have impaired concentration
Feel scalp tenderness
Some feel
Unusually refreshed or euphoric, OR
Have depression and malaise.
Status migrainosus
•Attacks that persist for more than 3
daysare known as Status Migraine
•Attack
Course and outcome of
Migraine
•Commonly life long
•Frequency and
severity varies
•½ will have less
frequent migraine
•1/3will have no
migraine
•1/6 will have
unchanged course
•Temporary relief
during pregnancy
•Increased
susceptibility
during menses
•Improvement
during menopause
•Changing pattern
of the headache
Treatment of Migraine
1.Treating the acute migraine headache
When migraine frequency is once per
week or less
Analgesics –ASA, paracetamol,
ibuprofen
Ergotamine -1-2 mg during the aura
phase or at the onset of headache
Antiemetics–promethazine25 mg
stat
For migraine status –corticosteroid
Treatment of Migraine cont’d
2. Prophylactic treatment
When migraine frequency is twice or
more per week
Drugs are given daily irrespective of
whether the headache occurs or not
Treatment duration: after 6 months of
stable state trial of drug withdrawal
1-Anti-depressant drugs
Tricyclics/venlafaxine appear effective, but
SSRIs –not usefu
Amitryptyline –10-50mg(150) mg /day
dothiepin 25 mg/day
2-Beta-blockers
Propranolol 40–240 mg/day, should be
avoided in asthma
Others (eg, metoprolol,atenolol, timolol,
nadolol) -probably as effective as
propranolol
Treatment of Migraine cont’d
3. Avoiding precipitating factors
Specific for each individual
Give awareness so that they
recognize the precipitant and avoid
it
Dietary
Specific odors
Emotional
Weather,. etc
Cluster Headache
(Previously called migrainous
neuralgia)
Cluster headache is a primary headache disorder of
unclear etiology. It is more common in males, and is
often precipitated by ingestion of alcohol. Not
infrequently, the patient awakes from sleep with the
onset of the headache.
Clinical features
Acute, non-throbbing, unilateral
heaadache
No aura
Periorbital localization
Radiates to forehead, temple and
cheek
Occurs in clusters
Tend to occur nightly
Lasts 1-2 hours
Clinical features cont’d
Associated symptoms
Blocked nostrils
Rhinorrhea
Conjunctivitis
Flush and edema of cheeks
In 20%, family history of similar
headache
Common precipitating factor -alcohol
.
Treatment -for the period of the attack
•Ergotamine3 mg PO or 1mg IM
•Sumatriptan6 mg subcutaneous.
•Startprednisolone(50-75mg/day) and
verapamil(up to 240 mg/day, sometimes
higher) at the beginning of a cluster, tailing
the steroids after 2–3 weeks, but continuing
verapamiluntil the cluster has resolved.
•NSAID :Indometacin(up to225 mg/day)
–Start at 25 mg three times daily for first
week, then 50 mg three times daily for
second week, and 75 mg three times daily
in third week
to prevent recurrent episodes.
Prevention involves patient education
regarding precipitating factors,
possible lifestyle or habit changes that
may be helpful, and pharmacologic
measures.